Perceptive Informatics, a leading eClinical solutions provider and a subsidiary of PAREXEL International Corporation (NASDAQ: PRXL), today announced that it has appointed Vladimir Evilevitch, M.D., Ph.D., to the position of Associate Medical Director and Head of Cardiology and Nuclear Medicine in its Medical Imaging Group. Dr. Evilevitch, formerly a Regional Medical Advisor at Novartis Healthcare, will support the continued expansion of Perceptive’s expertise in cardiovascular imaging modalities and capabilities to advise clients on the use of imaging in cardiology trials to make earlier safety and efficacy assessments about their compounds.
At Novartis Healthcare, Dr. Evilevitch worked in the fields of oncology medical affairs and clinical development. He formerly served as a Chief Attending Physician in the Diagnostic Imaging Division at Malmoe University Hospital in Sweden, where he was responsible for cardiac imaging interpretation for clinical care. Dr. Evilevitch has extensive experience in several imaging modalities, including cardiac Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT), as well as Multi Gated Acquisition Scan (MUGA), echocardiography, and others. As a Visiting Scientist at the National Institutes of Health (NIH) he worked in cardiovascular translational medicine with micro-Computed Tomography (CT) applications. Dr. Evilevitch received his M.D. and Ph.D. degrees from the Lund University in Sweden. He completed his post doctoral fellowship at the University of California, Los Angeles (UCLA) in the Department of Molecular and Medical Pharmacology, Nuclear Medicine Clinic. Dr. Evilevitch is author of several peer-reviewed scientific publications in the fields of physiology and oncology. His work has been recognized by the Swedish Society of Medicine and American Society of Clinical Oncology (ASCO).
“Perceptive is extremely pleased to have Dr. Evilevitch join our team of medical imaging experts. We believe that his experience in international biopharmaceutical development and nuclear imaging modalities will help to expand our capabilities to effectively guide our clients in their imaging-based trials,” said Kenneth G. Faulkner, Ph.D., Vice President of Medical Imaging, Perceptive Informatics. “Our goal is to assist clients in making better decisions about their compounds in order to bring new safe and effective treatments to patients sooner.”
Experts from the Perceptive Informatics Medical Imaging Group will be available at the American Heart Association Scientific Sessions, being held November 14-16 in Chicago, Illinois, to discuss Perceptive’s capabilities to support imaging-based cardiology trials. Experts at the Perceptive Booth #2428 in the exhibit hall will demonstrate leading image processing and analysis tools and proprietary image management applications. Perceptive experts will also address advantages of centralized, global cardiovascular review services.
The Medical Imaging Group of Perceptive Informatics offers a full range of capabilities in the application of imaging techniques from early clinical development through peri-approval studies. The medical imaging team operates globally and services a wide range of therapeutic areas, including cardiology, oncology, neurology, rheumatology, and endocrinology. Perceptive's sophisticated medical imaging technologies are fully validated, and rigorously designed to achieve high data quality. For more information about Perceptive Informatics, visit: www.perceptive.com.